Literature DB >> 17336425

Manipulation of serotonin signal suppresses early phase of behavioral aging in Caenorhabditis elegans.

Hana Murakami1, Karalee Bessinger, Jason Hellmann, Shin Murakami.   

Abstract

Aging is associated with progressive changes in behavioral functions, in part caused by muscle frailty, called sarcopenia. However, it was not clear whether certain neurotransmitters are directly involved in behavioral aging. Here we investigated aging of locomotion behaviors with an associative learning property, called basal and enhanced slowing response in Caenorhabditis elegans. Basal slowing response is a modest slowdown in response to food, while enhanced slowing response is a greater slowdown response when animals experience starvation. The behaviors are mediated by dopamine and serotonin, respectively. During aging, basal slowing response was increased, resulting in a diminished difference between the two slowing responses. The behavioral change occurred during early phase of aging prior to the timing when sarcopenia was observed in previous studies. Interestingly, expression of a serotonin biosynthesis marker, tph-1Colon, two colonsGFP, was increased in old animals. Serotonin receptor antagonists and deletion mutants of their target receptor genes (ser-1 and ser-4) partially suppressed age-related changes in locomotion behaviors. Thus, manipulating serotonin signal at receptor levels suppresses early phase of locomotion aging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336425     DOI: 10.1016/j.neurobiolaging.2007.01.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  EGF signaling comes of age: promotion of healthy aging in C. elegans.

Authors:  Simon Yu; Monica Driscoll
Journal:  Exp Gerontol       Date:  2010-11-11       Impact factor: 4.032

Review 2.  Between destiny and disease: genetics and molecular pathways of human central nervous system aging.

Authors:  Christin Glorioso; Etienne Sibille
Journal:  Prog Neurobiol       Date:  2010-12-02       Impact factor: 11.685

Review 3.  New haystacks reveal new needles: using Caenorhabditis elegans to identify novel targets for ameliorating body composition changes during human aging.

Authors:  Catherine A Wolkow
Journal:  Interdiscip Top Gerontol       Date:  2010-08-10

4.  Novel EGF pathway regulators modulate C. elegans healthspan and lifespan via EGF receptor, PLC-gamma, and IP3R activation.

Authors:  Hiroaki Iwasa; Simon Yu; Jian Xue; Monica Driscoll
Journal:  Aging Cell       Date:  2010-05-22       Impact factor: 9.304

5.  Applications of cold temperature stress to age fractionate Caenorhabditis elegans: a simple inexpensive technique.

Authors:  James D Willett; Neeraja Podugu; Gita Sudama; John J Kopecky; Jenefir Isbister
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-03-30       Impact factor: 6.053

6.  Increased whole cerebellar serotonin in aged C57BL/6 mice.

Authors:  Nicholas W DeKorver; Dustin Lichty; Marieke van der Hart; Arash Rassoulpour; Stephen J Bonasera
Journal:  Matters (Zur)       Date:  2017-03-09

7.  Diagnostic value and clinical significance of stress hormones in patients with tinnitus.

Authors:  Dong-Kee Kim; Dae Young Chung; Seung Chun Bae; Kyoung-Ho Park; Sang Won Yeo; Shi-Nae Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-26       Impact factor: 2.503

8.  Longevity manipulations differentially affect serotonin/dopamine level and behavioral deterioration in aging Caenorhabditis elegans.

Authors:  Jiang-An Yin; Xi-Juan Liu; Jie Yuan; Jing Jiang; Shi-Qing Cai
Journal:  J Neurosci       Date:  2014-03-12       Impact factor: 6.167

9.  Behavioral decay in aging male C. elegans correlates with increased cell excitability.

Authors:  Xiaoyan Guo; Andrew Navetta; Daisy G Gualberto; L Rene García
Journal:  Neurobiol Aging       Date:  2012-01-27       Impact factor: 4.673

10.  Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans.

Authors:  Marishka K Brown; Yuan Luo
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.